Squibb Secures Interim Injunction Against Zydus in Nivolumab Patent Dispute
The Delhi High Court has issued an interim injunction restraining Zydus from launching its Nivolumab biosimilar, siding with Squibb’s claim of imminent patent infringement.
Indian Patent Law
206 articles
Delhi HC Remands Oxidation Process Patent Rejection, Cites Invalid Section 2(1)(j) and 59 Findings
In the case of Treibacher Industrie AG v. Assistant Controller of Patents, the Delhi High Court set aside the refusal of a patent application for a catalytic oxidation…
Court Awards ₹50 Lakh to GSP Crop Science in Patent Infringement Case Over Agrochemical Formula
Delhi HC orders ₹50 lakh in damages to GSP Crop Science for patent infringement in agrochemicals, affirming seller liability under Indian patent law.
Patented Biologics and Section 104A: No Process Disclosure Without Proving Product Identity
Roche sued Zydus for infringing its process patent on Pertuzumab. The Delhi High Court held that Roche had not shown Zydus’s biosimilar was identical to its product. Without…
Who Bears the Patent Credibility Challenge Burden?
Mold Tek filed a case for infringement of its patents relating to tamper-proof plastic lids, and secured an interim injunction. The Commercial Court vacated the injunction, placing the…
Patent Application for System to Locate Users on P2P Networks Refused under Section 3(k)
The Delhi High Court has upheld the refusal of a patent application for a system that locates users on peer-to-peer networks. The Court ruled that the invention was…
Ziegler-Natta Catalyst Patent Rejection Upheld for Lack of Inventive Step
The Delhi High Court upheld the refusal of Lummus Novolen’s patent for a Ziegler-Natta catalyst, citing lack of inventive step and similarity to prior art. Read the key…
Patent on Carbon Capture Process freed from IPO refusal
The Madras High Court has overturned the rejection of a patent on a carbon capture process, citing the Patent Office's failure to adequately justify its decision and its…
Akebia’s patent for Anemia therapy gets fresh blood from Court
In a recent case the Madras High Court upheld Akebia Therapeutics’ appeal on its anaemia treatment patent, interpreting Section 59 to allow claim amendments from treatment methods to…
Blackberry’s Patent Refusal Set Aside by Delhi High Court
The Delhi High Court has set aside the Indian Patent Office’s refusal of Blackberry’s communication patent application. Citing a lack of reasoning and violation of natural justice principles,…